Principal Software Engineer

RapidAI presented 28 scientific abstracts at ISC 2026. RapidAI unveiled 28 scientific abstracts at ISC 2026, demonstrating how its FDA-cleared AI solutions enhance stroke detection, aneurysm monitoring, and radiology workflows, leading to improved accuracy and efficiency. Feb. 9, 2026 RapidAI announced details of 28 scientific abstracts accepted at the International Stroke Conference (ISC) 2026, held February 4-6, at the Ernest N. Morial Convention Center in New Orleans. The abstracts spanned aneurysm monitoring, ischemic stroke detection, advanced imaging visualization, and radiology workflow optimization. Findings reflect the impact of deep clinical AI delivered through the Rapid Enterprise platform, designed to scale across radiology and acute workflows. The clinical data demonstrates how RapidAI's clinically validated, FDA-cleared AI solutions can improve diagnostic performance, reduce interpretation time, and deliver measurable efficiency and economic gains for stroke teams and radiology departments. Rapid's Deep Clinical AI, delivers real results by providing not just triage notifications but also visualization, localization, characterization, and tracking changes over time.

RapidAI partners with Saudi Arabia's largest healthcare provider to advance Vision 2030 goals. RapidAI, a pioneer in deep clinical AI and intelligent imaging technology, has formed a strategic partnership with Health Holdings Company (HHC), Saudi Arabia's largest healthcare provider, to deploy advanced artificial intelligence systems across HHC's 20 health clusters nationwide. The collaboration represents a significant international expansion for the San Mateo-based company and directly supports the Health Sector Transformation Program, a key pillar of Saudi Arabia's Vision 2030 initiative aimed at modernizing the Kingdom's healthcare infrastructure. Enterprise-Scale AI deployment across 20 health clusters. According to the company, the partnership establishes RapidAI as HHC's enterprise provider of deep clinical AI, with implementation planned across neurology, cardiology, vascular, oncology, and orthopedic specialties. HHC provides healthcare services to more than 20 million people across Saudi Arabia through its network of hospitals and clinics, making this one of the largest regional deployments of clinical AI technology in the Middle East. The implementation will utilize RapidAI's Enterprise Platform and radiology solutions, integrating into existing clinical, radiology, and IT workflows to support care coordination and collaboration across departments and facilities. Ascend Solutions, a digital healthcare provider in the Saudi market, will provide on-the-ground operational services, including implementation, training, and optimization tailored for HHC's clinical teams and IT infrastructure. "Partnering with RapidAI aligns perfectly with our goal to transform and innovate on how care is delivered across our hospitals, from stroke to cardiac, vascular, and oncology, and to localize these capabilities for the Kingdom's Vision 2030." - Nasser Al Huqbani, CEO of Health Holdings Company "Partnering with RapidAI aligns perfectly with our goal to transform and innovate on how care is delivered across our hospitals, from stroke to cardiac, vascular, and oncology, and to localize these capabilities for the Kingdom's Vision 2030," said Nasser Al Huqbani, CEO of Health Holdings Company. Advancing Saudi Vision 2030 healthcare goals. The partnership directly supports Saudi Arabia's Health Sector Transformation Program, which aims to enhance healthcare quality and accessibility across the Kingdom. The program, established in 2022 under Vision 2030, focuses on transitioning healthcare delivery through digital transformation, value-based care models, and public-private partnerships. Vision 2030 represents Saudi Arabia's strategic framework to diversify its economy and transform public services, with healthcare as a major focus area. The Kingdom's healthcare transformation includes plans to establish health clusters as accountable care organizations, expand digital health capabilities, and attract international partnerships to support infrastructure modernization. According to the Health Sector Transformation Program, Saudi Arabia is working to reduce preventable mortality from non-communicable diseases, increase life expectancy from 75 to 80 years by 2030, and ensure universal health coverage for all citizens and residents. The deployment of advanced clinical AI systems like RapidAI's platform supports these objectives by enhancing diagnostic capabilities and care coordination across the Kingdom's healthcare network. Deep clinical AI for multiple disease states. RapidAI's approach to clinical AI emphasizes solving clinical problems rather than simply detecting conditions. The company's technology goes beyond basic triage alerts to provide what it describes as "deep clinical AI" capabilities, including characterization, quantification, visualization, and longitudinal tracking of clinical conditions. The company reports its solutions are currently deployed in more than 2,500 hospitals across 100 countries, with validation supported by over 700 clinical studies. The multi-specialty deployment approach allows HHC's clinical teams to utilize AI-powered tools across various disease states, potentially improving diagnostic speed and accuracy while supporting more coordinated care delivery across the health cluster network. Strategic implications for Middle East healthcare technology. The RapidAI-HHC partnership signals growing momentum for clinical AI adoption in the Middle East, particularly as Gulf nations invest heavily in healthcare infrastructure and digital transformation. Saudi Arabia's commitment to healthcare modernization, backed by substantial government funding, creates opportunities for international healthcare technology companies to establish regional partnerships. For RapidAI, the partnership provides a substantial foothold in a strategically important market and demonstrates the scalability of its Enterprise Platform across large, distributed healthcare networks. The collaboration also highlights the increasing importance of localization capabilities, with Ascend Solutions providing culturally and linguistically appropriate implementation support for Saudi clinical teams. The partnership structure - combining international technology expertise with local implementation capabilities - may serve as a model for future healthcare AI deployments in the region as other Gulf nations pursue similar digital transformation initiatives. Implementation timeline and regional impact. While specific implementation timelines were not disclosed in the announcement, the partnership positions HHC to accelerate its digital transformation strategy across all 20 health clusters. The scale of the deployment - spanning multiple disease states and clinical specialties across a nationwide network - represents a significant commitment to AI-enabled care delivery. For Saudi patients, the deployment of RapidAI's technology across HHC facilities could mean faster diagnosis and treatment for time-sensitive conditions like stroke and cardiac emergencies, along with improved care coordination as patients move between facilities within the health cluster system. The focus on prevention and early detection aligns with Vision 2030's emphasis on preventive care and reducing the burden of chronic disease. As Saudi Arabia continues its healthcare transformation journey, partnerships like this one between established international technology providers and the Kingdom's largest healthcare institution demonstrate the practical implementation of Vision 2030's ambitious healthcare goals, translating policy objectives into operational reality for millions of patients across the Kingdom. - This original article was created with AI support.